The Leadership Team at Engrail Therapeutics is responsible for strategic decision-making and guiding the company's mission to develop and commercialize innovative therapies for patients with life-limiting nervous system diseases. Comprising experts in commercial strategy, pre-clinical development, and scientific leadership, the team collaborates to align research initiatives with business objectives, ensuring the successful advancement of transformative medicines from laboratory to market.